Peribulbar block in adult patients undergoing cataract surgery..
Conditions
Interventions
Intervention 1: Control group (Group C): Includes 20 patients. Each will receive 9 ml of lidocaine 2% (containing 1 ml = 10 unit of hyaluronidase) + 1 ml of saline. Intervention 2: Intervention group
Sponsors
Research Institute of Ophthalmology
Eligibility
Sex/Gender
All
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: Cataract surgery patients (male or female) aged from 30 to 70 years ASA physical status I, II, or III
Exclusion criteria
Exclusion criteria: Coagulopathy or use of anticoagulant drugs Infection at the site of surgery Posterior staphyloma Previous allergy or adverse reaction to the used drugs Bronchial asthma or bradyarrhythmia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemodynamics (heart rate, blood pressure, and oxygen saturation). Timepoint: Baseline, immediately after the block, and one hour after the block. Method of measurement: Electronic vital signs monitor.;Onset of sensory block. Timepoint: Every 5 seconds after the block. Method of measurement: Clinical assessment.;Onset of motor block. Timepoint: Every 5 seconds after the block. Method of measurement: Clinical assessment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of the block. Timepoint: Every 10 minutes following the block. Method of measurement: Clinical assessment.;Postoperative pain. Timepoint: Immediately after the block. Method of measurement: Visual analog scale.;Surgeon satisfaction. Timepoint: Immediately after the block. Method of measurement: Questioning.;Patient satisfaction. Timepoint: Immediately after the block. Method of measurement: Questioning.;First analgesic dose. Timepoint: Every 30 minutes. Method of measurement: Clinical assessment. | — |
Countries
Egypt
Contacts
Public ContactDr. Iman Sobhy
Research Institute of Ophthalmology
Outcome results
None listed